Abstract
Multivalent lectin-glycan interactions (MLGIs) are widespread and vital for pathogen infection, cell-cell communication and immune regulation, making them attractive therapeutic targets. Despite significant efforts, research progress in MLGI targeting therapeutics remain limited, due to incomplete understanding of the structural and biophysical mechanisms of some key MLGIs which has hampered the design of spatial matched multivalent therapeutics. Moreover, the overlapping glycan specificities of various lectins makes it difficult to target specific MLGIs with high potency and selectivity. To address this challenge, we have recently developed polyvalent glycan-nanoparticles (glycan-NPs) as new biophysical probes for MLGIs: the NPs’ unique, size-dependent optical properties are exploited as readouts for quantifying MLGI affinities and thermodynamics, while their nanoscale size and high electron microscopy contrast are employed for probing binding modes and site orientation. Despite success, how design features such as glycan type, density and linker flexibility govern glycan-NP MLGI properties remain underexplored. Herein, we coat gold nanoparticles (GNPs) with varying densities of lipoic acid-oligo(ethylene glycol)--manno--1,2-biose or -fucose ligand of varying linker lengths and studied their MLGIs with DC-SIGN, an important tetrameric lectin viral receptor found on dendritic cells. Using our recently established GNP fluorescence quenching assay, we reveal that displaying DiMan or Fuc polyvalently on GNP surface greatly enhances their DC-SIGN affinity, with low nM Kds, ~300,000 fold tighter than the corresponding monovalent binding. Their bindings are enthalpy driven, with favorable enthalpic terms but unfavorable entropic terms and their absolute values depend on linker flexibility and glycan density. At high glycan densities, a short and less flexible linker is favored by maximizing enthalpic gains while minimizing entropic penalties; whereas at low glycan densities, a long and flexible linker is favored by increasing the reach and adaptivity of terminal glycans to maximize favorable enthalpic gains. Finally, we demonstrate GNP-glycans potently block DC-SIGN augmented viral entry to host cells with sub-nM IC50s, with IC50 values being positively linked to their DC-SIGN MLGI affinity.
Supplementary materials
Title
Supporting information
Description
Materials, instruments, and methods showing the synthesis and characterization of the LA-EGn-glycans by 1H/13C NMR spectra; determination of glycan valency; surface footprint calculation; the production, characterization and labeling of DC-SIGN by HR-MS and DLS; UV-vis and DLS histograms of citrate stabilized G5; DLS histograms of G5-EGn-glycans and G5-EGn-glycan plus varying ratios of DC-SIGN; the QE vs. C plots fitted with Hill’s equation; van‘t Hoff plots with linear fits of the ln(Kd)-(1/T) relationships for G5-glycans (LGMR 500 and 300) binding with DC-SIGN, and the unprocessed virus inhibition data showing the relevant cellular luciferase activities after treatment with the different G5-EGn-glycan inhibitors.
Actions



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)